Navigation Links
Renowned Duke researcher wins Frontiers of Knowledge Award
Date:1/27/2010

DURHAM, N.C. -- The prestigious BBVA Foundation Frontiers of Knowledge Award in the Biomedicine category goes this year to Robert J. Lefkowitz, M.D., James B. Duke Professor of Medicine and Biochemistry and a Howard Hughes Medical Institute (HHMI) investigator at Duke University Medical Center. This is only the second year the award has been given.

Dr. Lefkowitz's research has affected millions of cardiac and other patients worldwide. Lefkowitz proved the existence of, isolated, characterized and still studies G-protein-coupled receptors (GPCRs). The receptors, which are located on the surface of the membranes that surround cells, are the targets of almost half of the drugs on the market today, including beta blockers for heart disease, antihistamines and ulcer medications. Lefkowitz, a Duke faculty member since 1973, also investigates related enzymes, proteins and signaling pathways and continues to learn all he can about these pivotal receptors.

"I am surprised, delighted and honored by the award, and am honored to be in the company of Joan Massagu, a fellow HHMI investigator who won last year," said Lefkowitz, who is also a Duke professor of immunology and a basic research cardiologist in the Duke Heart Center. "While it is a relatively new award, I know it is a very distinguished award and I am delighted to be the recipient."

The BBVA Frontiers of Knowledge Award in Biomedicine provides the winner a cash prize of 400,000 euros (about $563,400). The award, organized by the BBVA Foundation in partnership with Spain's National Research Council, was announced at 11 a.m. Madrid time on Jan. 27.

Dr. Lefkowitz is being awarded the prize for the work he has done since the beginning of his career and includes his ongoing studies of GPCRs and other key receptors. His research group first identified, purified and cloned the genes for these receptors in the 1970s and 1980s, and revealed the structure of the receptors as well their functions and regulation. This work facilitated and fundamentally altered the way in which numerous therapeutic agents have been developed.

Lefkowitz is also extremely proud of his mentoring work and of the students and fellows he has worked with over the years, many of whom have gone on to run successful laboratories and uncover their own discoveries about GPCRs and other receptors.


'/>"/>

Contact: Mary Jane Gore
mary.gore@duke.edu
919-660-1309
Duke University Medical Center
Source:Eurekalert

Related medicine news :

1. The Eye Institute of Utah Hosts World Renowned Cataract Surgeons: In Economically Trying Times, Nine Fortunate Patients Receive State of the Art Cataract Lenses
2. First New OTC Headache Brand in 15 Years; Renowned Doctor Introduces Powerful Headache Medicine
3. Renowned Cardiologist Offers Heart Healthy Tips for the Holiday Season
4. Breakthrough Approach to Age-old Ailment, Renowned Doctor Introduces Powerful Headache Medicine
5. World-Renowned Vascular Surgeon to Conduct Training at Harvard Medical School Site on Non-Invasive Treatment of Veins
6. Renowned cardiovascular researcher to receive Taylor Prize
7. Garth Fisher, M.D.(R), F.A.C.S., Announces Adoption of LifeSculpt Body Sculpting Within His World-Renowned Plastic Surgery Practice
8. Patrick Soon-Shiong, World Renowned Healthcare Visionary & Philanthropist, to Receive ABL's Leadership Award & Make Keynote Presentation, October 28, in Newport Beach
9. Renowned Geriatrician Tracy Hoffman Tapped as Corporate Director of Memory Care Excellence By Fast-Growing CRL
10. Renowned Southern California Doctors Emphasizing Early Detection During Breast Cancer Awareness Month
11. Video: Eat Tastefully Campaign: Diet Coke, Renowned Chef, Pop-Up Kitchen Reveal Secrets to Great Taste, Living Well
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... ... Usually, the impending arrival of warmer weather means the gleeful banishment of ... chin, this means more anxiety than elation. The cosmetic dermatology experts at Cosmetic Laser ... chin is undesirable,” Dr. Goldman said, “but it seems doubly so when the fat ...
(Date:3/28/2017)... ... March 28, 2017 , ... Calibration, qualification, ... ensuring high-quality results and maintaining GMP and USP compliance. In a new webinar ... with GMP requirements " these requirements are explained. The challenge is to ...
(Date:3/28/2017)... ... March 28, 2017 , ... Qualidigm , the mission-driven ... to a new, more expansive office space in order to accommodate its growing ... distressed office building in Wethersfield, Conn. located at 936 Silas Deane Highway and ...
(Date:3/28/2017)... ... 2017 , ... With less than 10,000 dermatologists in the United States and ... limited while the desire to conquer breakouts and eliminate skincare stress is widespread. ... online, today released its inaugural survey on the State of Acne in America. ...
(Date:3/28/2017)... ... March 28, 2017 , ... In its ongoing ... website has recently developed and published an informational resource that addresses frequently asked ... on common inquiries the site’s team of third party administrator (TPA) contributors regularly ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... TAIPEI, Taiwan , March 28, 2017 /PRNewswire/ ... medical device company, is pleased to announce ... Series A investment of Panther Orthopedics, Inc., a ... pioneering innovative dynamic fixation solutions for orthopedic extremity ... market continues to expand rapidly, primarily due to ...
(Date:3/28/2017)...  "US Cancer Generics Market Outlook 2022" report ... trend analysis related to the emergence and integration ... in US. The report analyzes various clinical and ... generics drugs in recent years. The introduction of ... dollars for various stake holders involved US cancer ...
(Date:3/28/2017)... -- Orexigen Therapeutics, Inc. (Nasdaq: OREX ) today ... and year ended December 31, 2016. ... Orexigen, beginning with the re-acquisition of the rights to ... team at Orexigen demonstrated remarkable focus, executing on a ... our Company while rewarding us full control of our ...
Breaking Medicine Technology: